Out of Control: The Flawed Regulation of Schedule II Drugs and Its Impact on Pain and Addiction

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Sands, Darin M.	en_US
dc.date.accessioned	2012-06-07T20:10:34Z
dc.date.issued	2004	en_US
dc.identifier.citation	Out of Control: The Flawed Regulation of Schedule II Drugs and Its Impact on Pain and Addiction (2004 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852114
dc.description.abstract	This paper explores the current state of regulation of controlled substances at the federal and state level and analyzes how such regulations impact the undertreatment of pain and prescription drug abuse. Taking a historical view of the pain treatment movement and using the recent OxyContin crisis as a case study, the future of controlled substance policy as it relates to painkillers is analyzed. It argues that any successful policy will have to do a better job of balancing law enforcement and health care goals.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	pain	en
dc.subject	painkillers	en
dc.subject	pain treatment	en
dc.title	Out of Control: The Flawed Regulation of Schedule II Drugs and Its Impact on Pain and Addiction	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T20:10:34Z